Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study-Reference-Cited by-同舟云学术

Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study

Published:2019-04 Issue:4 Volume:80 Page:913-921.e9
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Guttman-Yassky Emma,Silverberg Jonathan I.,Nemoto Osamu,Forman Seth B.,Wilke August,Prescilla Randy,de la Peña Amparo,Nunes Fabio P.,Janes Jonathan,Gamalo Margaret,Donley David,Paik Jim,DeLozier Amy M.,Nickoloff Brian J.,Simpson Eric L.

Publisher

Elsevier BV

Subject

Dermatology

Reference27 articles.

1. The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies;Brunner;J Allergy Clin Immunol,2017

2. Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation;Schmitt;J Allergy Clin Immunol,2013

3. Public health burden and epidemiology of atopic dermatitis;Silverberg;Dermatol Clin,2017

4. Global Allergy Forum and 3rd Davos Declaration 2015: atopic dermatitis/eczema: challenges and opportunities toward precision medicine;Bieber;Allergy,2016

5. Atopic dermatitis: racial and ethnic differences;Mei-Yen;Dermatol Clin,2017

Cited by 259 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Schizonepeta tenuifolia Briq-Saposhnikovia divaricata decoction alleviates atopic dermatitis via downregulating macrophage TRPV1;Frontiers in Pharmacology;2024-08-27

2. Revisiting immunotherapeutic strategies for the management of atopic dermatitis;Exploration of Asthma & Allergy;2024-08-09

3. Systemic Immunomodulatory Treatments for Atopic Dermatitis;JAMA Dermatology;2024-07-17

4. Cost-Effectiveness of Dupilumab and Oral Janus Kinase Inhibitors for the Treatment of Moderate-to-Severe Atopic Dermatitis in Singapore;PharmacoEconomics - Open;2024-07-13

5. Baricitinib protects ICIs-related myocarditis by targeting JAK1/STAT3 to regulate Macrophage polarization;Cytokine;2024-07